Related references
Note: Only part of the references are listed.Integration of IgA and IgG Autoantigens Improves Performance of Biomarker Panels for Early Diagnosis of Lung Cancer
Jianbo Pan et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
NY-ESO-1 expression in solid tumors predicts prognosis A systematic review and meta-analysis
Huiyu Wang et al.
MEDICINE (2019)
Projections of primary liver cancer to 2030 in 30 countries worldwide
Patricia C. Valery et al.
HEPATOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Neopterin as a biomarker of immune response in cancer patients
Bohuslav Melichar et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Autoantibodies: Opportunities for Early Cancer Detection
Isabel K. Macdonald et al.
TRENDS IN CANCER (2017)
NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers
Yoko Oshima et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Use of Autoantibodies to Detect the Onset of Breast Cancer
Jerome Lacombe et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Des--carboxy prothrombin ratio measured by P-11 and P-16 antibodies is a novel biomarker for hepatocellular carcinoma
Masahiko Tameda et al.
CANCER SCIENCE (2013)
Evaluation of the effect of sorafenib using serum NX-des-γ-carboxyprothrombin in patients with hepatocellular carcinoma
Koji Miyahara et al.
HEPATOLOGY RESEARCH (2013)
Evaluation of Individual and Combined Applications of Serum Biomarkers for Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis
Bin Hu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Overexpression of Calreticulin in Malignant and Benign Breast Tumors: Relationship with Humoral Immunity
Aleksandra Eric-Nikolic et al.
ONCOLOGY (2012)
Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors
Jian-Ying Zhang et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2010)
Serum autoantibodies as biomarkers for early cancer detection
Hwee Tong Tan et al.
FEBS JOURNAL (2009)
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
Sean F. Altekruse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Autoantibodies to tumor-associated antigens: reporters from the immune system
Eng M. Tan et al.
IMMUNOLOGICAL REVIEWS (2008)
Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review
Ryosuke Tateishi et al.
HEPATOLOGY INTERNATIONAL (2008)
Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1
Hisako Higashitsuji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Coping with stress: multiple ways to activate p53
H. F. Horn et al.
ONCOGENE (2007)
Hematopoiesis controlled by distinct TIF1γ and Smad4 branches of the TGFβ pathway
Wei He et al.
CELL (2006)
Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma:: Both or neither?
F Farinati et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Germ-layer specification and control of cell growth by ectodermin, a Smad4 ubiquitin ligase
S Dupont et al.
CELL (2005)
Clinical significance of p53 antigen and anti-p53 antibodies in the sera of hepatocellular carcinoma patients
N Charuruks et al.
JOURNAL OF GASTROENTEROLOGY (2001)
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
AA Jungbluth et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Share Paper
